The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
Open accessAbstract
Recently emerged SARS-CoV-2 caused a major outbreak of coronavirus disease 2019 (COVID-19) and instigated a widespread fear, threatening global health safety. To date, no licensed antiviral drugs or vaccines are available against COVID-19 although several clinical trials are under way to test possible therapies. During this urgent situation, computational drug discovery methods provide an alternative to tiresome high-throughput screening, particularly in the hit-to-lead-optimization stage. Identification of small molecules that specifically target viral replication apparatus has indicated the highest potential towards antiviral drug discovery. In this work, we present potential compounds that specifically target SARS-CoV-2 vital proteins, including the main protease, Nsp12 RNA polymerase and Nsp13 helicase. An integrative virtual screening and molecular dynamics simulations approach has facilitated the identification of potential binding modes and favourable molecular interaction profile of corresponding compounds. Moreover, the identification of structurally important binding site residues in conserved motifs located inside the active site highlights relative importance of ligand binding based on residual energy decomposition analysis. Although the current study lacks experimental validation, the structural information obtained from this computational study has paved way for the design of targeted inhibitors to combat COVID-19 outbreak.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedTrott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00255 · Cited by 10,830
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
SWISS-MODEL: an automated protein homology-modeling server
Schwede, T. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg520 · Cited by 5,606
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,062
Hou, T., Wang, J., Li, Y., & Wang, W. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100275a · Cited by 2,773
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,474
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.008 · Cited by 2,330
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104787 · Cited by 2,179
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S. N., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,026
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., et al. (2020) · Science · doi:10.1126/science.abb7498 · Cited by 1,609
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Woo, P. C. Y., Lau, S. K. P., Chu, C.-M., Chan, K.-H., Tsoi, H.-W., Huang, Y., Wong, B. H. L., Poon, R. W. S., Cai, J. J., Luk, W.-K., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.884-895.2005 · Cited by 1,525
Return of the Coronavirus: 2019-nCoV
Gralinski, L. E., & Menachery, V. D. (2020) · Viruses · doi:10.3390/v12020135 · Cited by 1,348
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105932 · Cited by 937 · cited 1×
“Recently, hydroxychloroquine has shown to be effective in COVID-19 patients [7] and its efficiency has been reportedly reinforced by azithromycin for virus elimination [8], although no well-controlled, randomized clinical evidence supports azithromycin therapy in COVID-19 [9].”
Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020) · ChemBioChem · doi:10.1002/cbic.202000047 · Cited by 776
Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030324 · Cited by 727
The 2019‐new coronavirus epidemic: Evidence for virus evolution
Benvenuto, D., Giovanetti, M., Ciccozzi, A., Spoto, S., Angeletti, S., & Ciccozzi, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25688 · Cited by 713
Structural basis for RNA replication by the hepatitis C virus polymerase
Appleby, T. C., Perry, J. K., Murakami, E., Barauskas, O., Feng, J., Cho, A., Fox, D., Wetmore, D. R., McGrath, M. E., Ray, A. S., et al. (2015) · Science · doi:10.1126/science.1259210 · Cited by 339
Jia, Z., Yan, L., Ren, Z., Wu, L., Wang, J., Guo, J., Zheng, L., Ming, Z., Zhang, L., Lou, Z., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz409 · Cited by 334
Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase
Gong, P., & Peersen, O. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007626107 · Cited by 313
Identification of Novel Inhibitors of the SARS Coronavirus Main Protease 3CLpro
Bacha, U., Barrila, J., Velazquez-Campoy, A., Leavitt, S. A., & Freire, E. (2004) · Biochemistry · doi:10.1021/bi0361766 · Cited by 218
3C-like Proteinase from SARS Coronavirus Catalyzes Substrate Hydrolysis by a General Base Mechanism
Huang, C., Wei, P., Fan, K., Liu, Y., & Lai, L. (2004) · Biochemistry · doi:10.1021/bi036022q · Cited by 215
http://Mcule.com: a public web service for drug discovery
Kiss, R., Sandor, M., & Szalai, F. A. (2012) · Journal of Cheminformatics · doi:10.1186/1758-2946-4-s1-p17 · Cited by 185
Tan, J., Verschueren, K. H. G., Anand, K., Shen, J., Yang, M., Xu, Y., Rao, Z., Bigalke, J., Heisen, B., Mesters, J. R., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.012 · Cited by 184
Potential antivirals and antiviral strategies against SARS coronavirus infections
De Clercq, E. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.2.291 · Cited by 176
Prediction and Optimization of Pharmacokinetic and Toxicity Properties of the Ligand
Pires, D. E. V., Kaminskas, L. M., & Ascher, D. B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7756-7_14 · Cited by 156
Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitroPreprint
Yamamoto, N., Matsuyama, S., Hoshino, T., & Yamamoto, N. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.06.026476 · Cited by 136
Chemoinformatics and Computational Chemical Biology
(2010) · Methods in molecular biology · doi:10.1007/978-1-60761-839-3 · Cited by 116
Srivastava, H. K., & Sastry, G. N. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300385h · Cited by 115
Picornaviral polymerase structure, function, and fidelity modulation
Peersen, O. B. (2017) · Virus Research · doi:10.1016/j.virusres.2017.01.026 · Cited by 99
Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19)
Zhu, R.-F., Gao, Y.-L., Robert, S.-H., Gao, J.-P., Yang, S.-G., & Zhu, C. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02442-5 · Cited by 76
Jones, P., Storer, R. I., Sabnis, Y. A., Wakenhut, F., Whitlock, G. A., England, K. S., MUKAIYAMA, T., Dehnhardt, C. M., Coe, J. W., Kortum, S. W., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01634 · Cited by 57
ADME Profiling in Drug Discovery and a New Path Paved on Silica
Krüger, A., Maltarollo, V. G., Wrenger, C., & Kronenberger, T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86174 · Cited by 56
Mirza, M. U., & Ikram, N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111748 · Cited by 53
Self-citationPerspectives towards antiviral drug discovery against Ebola virus
Mirza, M. U., Vanmeert, M., Ali, A., Iman, K., Froeyen, M., & Idrees, M. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25357 · Cited by 45
Self-citationMirza, M. U., Vanmeert, M., Froeyen, M., Ali, A., Rafique, S., & Idrees, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-43129-2 · Cited by 45
Self-citationChang, H.-P., Chou, C., & Chang, G. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.091736 · Cited by 40
Ikram, N., Mirza, M. U., Vanmeert, M., Froeyen, M., Salo‐Ahen, O. M. H., Tahir, M., Qazi, A. M., & Ahmad, S. (2019) · Biomolecules · doi:10.3390/biom9040124 · Cited by 34
Self-citationMirza, M. U., Ghori, N.-U.-H., Ikram, N., Adil, A. R., & Manzoor, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s75886 · Cited by 29
Self-citation
Cited by
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
Pachetti, M., Marini, B., Benedetti, F., Giudici, F., Mauro, E., Storici, P., Masciovecchio, C., Angeletti, S., Ciccozzi, M., Gallo, R. C., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02344-6 · Cited by 996
C, S., S., D. K., Ragunathan, V., Tiwari, P., A., S., & P, B. D. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1815584 · Cited by 375
Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761883 · Cited by 338
Cosolvent and Dynamic Effects in Binding Pocket Search by Docking Simulations
(2021) · doi:10.1021/acs.jcim.1c00924 · Cited by 9
Metadata
- Authors
- Mirza, M. U., & Froeyen, M.
- Venue
- Journal of Pharmaceutical Analysis
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 10
- Issue
- 4
- Pages
- 320-328
- ISSN
- 2095-1779 (ISSN-L)
- OpenAlex
- W3010880616
- Cited by
- 284
- References
- 49
- FWCI
- 30.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.